The Rutgers University Center for COVID-19 Response and Pandemic Preparedness (CCRP2) serves as an institutional hub for COVID-19 research activities and information dissemination. The rapid spread of SARS-CoV-2 and the ongoing COVID-19 pandemic present unprecedented challenges to global health and scientific discovery. In 2020, Rutgers University created the CCRP2, a part of the Institute for Infectious and Inflammatory Diseases, to quickly respond to the global COVID-19 pandemic and to stimulate transformative solutions for challenges at the local, national and international levels.
The following CCB faculty received awards for their COVID-19 research:
- Computational Tools for COVID-19 Mpro Inhibitor Design and Precision Medicine: Drs. Darrin York and David Case
- The essential role of protein motions in therapeutic design: understanding how dynamics regulate SARS-CoV-2 spike RBD-ACE2 interactions: Dr. Jean Baum
- Fragment based ligand discovery against SARS-CoV-2 papain-like protease: Dr. Sagar Khare (with Drs. Nilgun Tumer and Xiao-Ping Li of Plant Biology)
- Structural and Small-Molecule Binding Studies of SARS-CoV-2 Polyproteins and Proteins: Dr. Edward Arnold (with Dr. Jason Kaelber of IQB)
- Super-effective face masks with internal decontamination of virus particles: Dr. Joachim Kohn (with Drs. Sanjeeva Murthy and Kim-Phuong Le of NJCBM)